Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Recent Analysis Shows Philip Morris, Danaher, Skechers, Sally Beauty, Spectrum Pharma, and Textron Market Influences – Renewed Outlook, Key Drivers of Growth

PM, DHR, SBH, C.PM

NEW YORK, Nov. 07, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Philip Morris International Inc. (NYSE:PM), Danaher Corporation (NYSE:DHR), Skechers U.S.A., Inc. (NYSE:SKX), Sally Beauty Holdings, Inc. (NYSE:SBH), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), and Textron Inc. (NYSE:TXT) including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

PM DOWNLOAD: http://Fundamental-Markets.com/register/?so=PM

DHR DOWNLOAD: http://Fundamental-Markets.com/register/?so=DHR

SKX DOWNLOAD: http://Fundamental-Markets.com/register/?so=SKX

SBH DOWNLOAD: http://Fundamental-Markets.com/register/?so=SBH

SPPI DOWNLOAD: http://Fundamental-Markets.com/register/?so=SPPI

TXT DOWNLOAD: http://Fundamental-Markets.com/register/?so=TXT

 (You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine  Philip Morris International Inc. (NYSE:PM), Danaher Corporation (NYSE:DHR), Skechers U.S.A., Inc. (NYSE:SKX), Sally Beauty Holdings, Inc. (NYSE:SBH), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), and Textron Inc. (NYSE:TXT) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. All information in this release was accessed November 6, 2017. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All amounts in millions (except per share amounts).

-----------------------------------------

PHILIP MORRIS INTERNATIONAL INC. (PM) REPORT OVERVIEW

Philip Morris' Recent Financial Performance

For the three months ended September 30, 2017 vs September 30, 2016, Philip Morris reported revenue of $56,513 vs $55,764 (up 1.4%), diluted earnings per share $3.43 vs $3.38 (up 1.5%), and dividends per share $3.15 vs $3.08 (up 2.3%). For the twelve months ended December 31, 2016 vs December 31, 2015, Philip Morris reported revenue of $74,953 vs $73,908 (up 1.4%), diluted earnings per share $4.48 vs $4.42 (up 1.4%), and dividends per share $4.12 vs $4.04 (up 2.0%).

To read the full Philip Morris International Inc. (PM) report, download it here: http://Fundamental-Markets.com/register/?so=PM

-----------------------------------------

DANAHER CORPORATION (DHR) REPORT OVERVIEW

Danaher's Recent Financial Performance

For the three months ended September 29, 2017 vs September 30, 2016, Danaher reported revenue of $4,528.2 vs $4,132.1 (up 9.6%), diluted earnings per share $0.81 vs $0.56 (up 44.6%). For the twelve months ended December 31, 2016 vs December 31, 2015, Danaher reported revenue of $16,882.4 vs $14,433.7 (up 17.0%), diluted earnings per share $3.65 vs $4.74 (down 23.0%).

To read the full Danaher Corporation (DHR) report, download it here: http://Fundamental-Markets.com/register/?so=DHR

-----------------------------------------

SKECHER U.S.A., INC. (SKX) REPORT OVERVIEW

Skechers' Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, Skechers reported revenue of $1,025.9 vs $877.8 (up 17.9%), diluted earnings per share $0.38 vs $0.48 (down 20.8%). For the twelve months ended December 31, 2016 vs December 31, 2015, Skechers reported revenue of $3,563.3 vs $3,147.3 (up 13.2%), diluted earnings per share $1.57 vs $1.50 (up 4.7%).

To read the full Skechers U.S.A., Inc. (SKX) report, download it here: http://Fundamental-Markets.com/register/?so=SKX

-----------------------------------------

SALLY BEAUTY HOLDINGS, INC. (SBH) REPORT OVERVIEW

Sally Beauty's Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, Sally Beauty reported revenue of $998.0 vs $998.2 (down 0.02%), diluted earnings per share $0.49 vs $0.46 (up 6.5%). For the twelve months ended December 31, 2016 vs December 31, 2015, Sally Beauty reported revenue of $3,952.6 vs $3,834.3 (up 3.1%), diluted earnings per share $1.50 vs $1.49 (up 0.7%). Sally Beauty is expected to report earnings on 11/15/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 11 analysts' forecasts, the consensus EPS forecast for the quarter is $0.47. The reported EPS for the same quarter last year was $0.41.

To read the full Sally Beauty Holdings, Inc. (SBH) report, download it here: http://Fundamental-Markets.com/register/?so=SBH

-----------------------------------------

SPECTRUM PHARMACEUTICALS, INC. (SPPI) REPORT OVERVIEW

Spectrum Pharma's Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, Spectrum Pharma reported revenue of $34.3 vs $33.9 (up 1.2%), diluted earnings per share -$0.26 vs -$0.35. For the twelve months ended December 31, 2016 vs December 31, 2015, Spectrum Pharma reported revenue of $146.4 vs $162.6 (down 10.0%), diluted earnings per share -$0.94 vs -$0.78.

To read the full Spectrum Pharmaceuticals, Inc. (SPPI) report, download it here: http://Fundamental-Markets.com/register/?so=SPPI

-----------------------------------------

TEXTRON INC. (TXT) REPORT OVERVIEW

Textron's Recent Financial Performance

For the three months ended September 30, 2017 vs October 1, 2016, Textron reported revenue of $3,484 vs $3,251 (up 7.2%), diluted earnings per share $0.60 vs $1.55 (down 61.3%), and dividends per share $0.02 vs $0.02 (unchanged). For the twelve months ended December 31, 2016 vs December 31, 2015, Textron reported revenue of $13,788 vs $13,423 (up 2.7%), diluted earnings per share $3.09 vs $2.50 (up 23.6%), and dividends per share $0.08 vs $0.08 (unchanged).

To read the full Textron Inc. (TXT) report, download it here: http://Fundamental-Markets.com/register/?so=TXT

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade—and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@fundamental-markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@fundamental-markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: andrew.duffie@fundamental-markets.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today